Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
US8158634B2 · kind B2 · utility
1Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2005 |
| Grant date | Apr 17, 2012 |
| Priority date | — |
| Expiry date | Dec 3, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds having Formula Ia,or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and Y are as defined in the specification; as well as pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.